India’s government has not put in any pre-orders for the Pfizer and Moderna vaccines that were first to report encouraging Phase 3 trial results. But, alongside the US, India has the largest order of any country for the Oxford/AstraZeneca vaccine. This vaccine is already being produced in India, by the Serum Institute, ready for it to receive government approval. And it should be easier to distribute than some other vaccine candidates since it doesn’t need to get kept extremely cold. The latest good news on the efficacy of the Oxford vaccine is therefore the most encouraging sign yet that India has a route to ending its COVID-19 epidemic and the social distancing that continues to weigh on the economy.
Subscriber content
Read this in full, free
Start a free trial and use one of your 10 free starter credits to unlock this piece.